StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30
$3.81−0.09 (-2.31%)

Close on Nov 18, 2026Market cap $43.25MP/E –Yield –

ImageneBio net income

Net income is the profit left for shareholders after every expense, interest and tax.

ImageneBio's net income for the twelve months ending Jun 30, 2026 was -$52.48M. For fiscal 2025 it was -$45.35M. The highest annual figure on record is -$34.12M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$45.35M–
FY2024Dec 31, 2024-$36.57M–
FY2023Dec 31, 2023-$68.17M–
FY2022Dec 31, 2022-$68.77M–
FY2021Dec 31, 2021-$34.12M–
FY2020Dec 31, 2020-$44.26M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.18M–
Q1 FY2026Mar 31, 2026-$10.62M–
Q4 FY2025Dec 31, 2025-$6.91M–
Q3 FY2025Sep 30, 2025-$24.78M–
Q2 FY2025Jun 30, 2025-$7.59M–
Q1 FY2025Mar 31, 2025-$6.08M–
Q4 FY2024Dec 31, 2024-$4.81M–
Q3 FY2024Sep 30, 2024-$3.18M–
Q2 FY2024Jun 30, 2024-$6.26M–
Q1 FY2024Mar 31, 2024-$22.31M–
Q4 FY2023Dec 31, 2023-$19.49M–
Q3 FY2023Sep 30, 2023-$17.34M–
Q2 FY2023Jun 30, 2023-$17.12M–
Q1 FY2023Mar 31, 2023-$14.22M–
Q4 FY2022Dec 31, 2022-$14.10M-604.0%
Q3 FY2022Sep 30, 2022-$17.34M–
Q2 FY2022Jun 30, 2022-$20.49M–
Q1 FY2022Mar 31, 2022-$16.84M–
Q4 FY2021Dec 31, 2021$2.80M–
Q3 FY2021Sep 30, 2021-$14.52M–
Q2 FY2021Jun 30, 2021-$12.68M–
Q1 FY2021Mar 31, 2021-$9.72M–
Q4 FY2020Dec 31, 2020-$26.05M–
Q3 FY2020Sep 30, 2020-$6.22M–
Q2 FY2020Jun 30, 2020-$5.04M–
Q1 FY2020Mar 31, 2020-$6.95M–

More ImageneBio figures

See a number that looks wrong?